Who
Steve Gavel
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, Cabaletta Bio.
In numbers
- Trades disclosed
- 3
- Buys
- 1
- Sells
- 0
- Bought
- $101K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 13 Oct 2025
- Last trade
- 21 Jan 2026
- Last filed
- 21 Jan 2026
Companies traded
Activity over time
1 Jan – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Jan 2026filed 21 Jan 2026 | CABA Cabaletta BioBiotechnology | SEC FORM 4 Bought | $50K22,170 at $2.27 | filing |
| 21 Jan 2026filed 21 Jan 2026 | CABA Cabaletta BioBiotechnology | SEC FORM 4 Bought | $50K22,170 at $2.27 | filing |
| 13 Oct 2025filed 15 Oct 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —275,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.